Low-dose bisphenol A and estrogen increase ventricular arrhythmias following ischemia-reperfusion in female rat hearts

Food and Chemical Toxicology

Volumn 56, Issue , 2013, Pages 75-80

  Yan, Sujuan ^a,b   Song, Weizhong ^b   Chen, Yamei ^b   Hong, Kui ^a   Rubinstein, Jack ^b   Wang, Hong Sheng ^b  

^a NANCHANG UNIVERSITY   (China)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Bisphenol A; Cardiac arrhythmias; Heart; Ischemic reperfusion injury

Indexed keywords

4,4' ISOPROPYLIDENEDIPHENOL; ESTRADIOL; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DAMAGE; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; DISEASE DURATION; DISEASE EXACERBATION; ELECTROGRAPHY; FEMALE; HEART ELECTROPHYSIOLOGY; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HORMONAL THERAPY; NONHUMAN; OUTCOME ASSESSMENT; RAT; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SUDDEN DEATH;

ANIMALS; ARRHYTHMIAS, CARDIAC; BENZHYDRYL COMPOUNDS; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOCRINE DISRUPTORS; ESTRADIOL; ESTROGENS; FEMALE; HEART; MALE; MYOCARDIAL INFARCTION; PHENOLS; RATS; RATS, SPRAGUE-DAWLEY; REPERFUSION INJURY;

EID: 84874805241     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2013.02.011     Document Type: Article

References (39)

1. Andrikopoulos G.K., Tzeis S.E., Pipilis A.G., Richter D.J., Kappos K.G., Stefanadis C.I., Toutouzas P.K., Chimonas E.T. Younger age potentiates post myocardial infarction survival disadvantage of women. Int. J. Cardiol. 2006, 108:320-325.
2. Babiker F.A., De Windt L.J., van Eickels M., Grohe C., Meyer R., Doevendans P.A. Estrogenic hormone action in the heart: regulatory network and function. Cardiovasc. Res. 2002, 53:709-719.
3. Balke C.W., Kaplinsky E., Michelson E.L., Naito M., Dreifus L.S. Reperfusion ventricular tachyarrhythmias: correlation with antecedent coronary artery occlusion tachyarrhythmias and duration of myocardial ischemia. Am. Heart. J. 1981, 101:449-456.
4. Barakat K., Wilkinson P., Suliman A., Ranjadayalan K., Timmis A. Acute myocardial infarction in women: contribution of treatment variables to adverse outcome. Am. Heart. J. 2000, 140:740-746.
5. Belcher S.M., Chen Y., Yan S., Wang H.S. Rapid estrogen receptor-mediated mechanisms determine the sexually dimorphic sensitivity of ventricular myocytes to 17beta-estradiol and the environmental endocrine disruptor bisphenol A. Endocrinology 2012, 153:712-720.
6. Bernier M., Manning A.S., Hearse D.J. Reperfusion arrhythmias: dose-related protection by anti-free radical interventions. Am. J. Physiol. 1989, 256:H1344-1352.
7. Booth E.A., Lucchesi B.R. Estrogen-mediated protection in myocardial ischemia-reperfusion injury. Cardiovasc. Toxicol. 2008, 8:101-113.
8. Carmeliet E. Cardiac ionic currents and acute ischemia: from channels to arrhythmias. Physiol. Rev. 1999, 79:917-1017.
9. Curtis M.J. Characterisation, utilisation and clinical relevance of isolated perfused heart models of ischaemia-induced ventricular fibrillation. Cardiovasc. Res. 1998, 39:194-215.
10. Diamanti-Kandarakis E., Bourguignon J.P., Giudice L.C., Hauser R., Prins G.S., Soto A.M., Zoeller R.T., Gore A.C. Endocrine-disrupting chemicals: an endocrine society scientific statement. Endocr. Rev. 2009, 30:293-342.
11. Gabel S.A., Walker V.R., London R.E., Steenbergen C., Korach K.S., Murphy E. Estrogen receptor beta mediates gender differences in ischemia/reperfusion injury. J. Mol. Cell Cardiol. 2005, 38:289-297.
12. Geens T., Aerts D., Berthot C., Bourguignon J.P., Goeyens L., Lecomte P., Maghuin-Rogister G., Pironnet A.M., Pussemier L., Scippo M.L., Van Loco J., Covaci A. A review of dietary and non-dietary exposure to bisphenol-A. Food Chem. Toxicol. 2012, 50:3725-3740.
13. Klein H., Puschmann S., Schaper J., Schaper W. The mechanism of the tetrazolium reaction in identifying experimental myocardial infarction. Virchows Arch. 1981, 393:287-297.
14. Kuhar P., Lunder M., Drevensek G. The role of gender and sex hormones in ischemic-reperfusion injury in isolated rat hearts. Eur. J. Pharmacol. 2007, 561:151-159.
15. LaCroix A.Z., Chlebowski R.T., Manson J.E., Aragaki A.K., Johnson K.C., Martin L., Margolis K.L., Stefanick M.L., Brzyski R., Curb J.D., Howard B.V., Lewis C.E., Wactawski-Wende J. Health outcomes after stopping conjugated equine estrogens among postmenopausal women with prior hysterectomy: a randomized controlled trial. JAMA 2011, 305:1305-1314.
16. Lang I.A., Galloway T.S., Scarlett A., Henley W.E., Depledge M., Wallace R.B., Melzer D. Association of urinary bisphenol A concentration with medical disorders and laboratory abnormalities in adults. JAMA 2008, 300:1303-1310.
17. Le H.H., Carlson E.M., Chua J.P., Belcher S.M. Bisphenol A is released from polycarbonate drinking bottles and mimics the neurotoxic actions of estrogen in developing cerebellar neurons. Toxicol. Lett. 2008, 176:149-156.
18. Lloyd-Jones D.M., Larson M.G., Beiser A., Levy D. Lifetime risk of developing coronary heart disease. Lancet 1999, 353:89-92.
19. Maxwell S.R., Lip G.Y. Reperfusion injury: a review of the pathophysiology, clinical manifestations and therapeutic options. Int. J. Cardiol. 1997, 58:95-117.
20. Melzer D., Rice N.E., Lewis C., Henley W.E., Galloway T.S. Association of urinary bisphenol a concentration with heart disease: evidence from NHANES 2003/06. PLoS One 2010, 5:e8673.
21. Melzer D., Osborne N.J., Henley W.E., Cipelli R., Young A., Money C., McCormack P., Luben R., Khaw K.T., Wareham N.J., Galloway T.S. Urinary bisphenol A concentration and risk of future coronary artery disease in apparently healthy men and women. Circulation 2012, 125:1482-1490.
22. Moens A.L., Claeys M.J., Timmermans J.P., Vrints C.J. Myocardial ischemia/reperfusion-injury, a clinical view on a complex pathophysiological process. Int. J. Cardiol. 2005, 100:179-190.
23. Murphy E., Steenbergen C. Gender-based differences in mechanisms of protection in myocardial ischemia-reperfusion injury. Cardiovasc. Res. 2007, 75:478-486.
24. Nelson H.D., Walker M., Zakher B., Mitchell J. Menopausal hormone therapy for the primary prevention of chronic conditions: a systematic review to update the U.S. preventive services task force recommendations. Ann. Int. Med. 2012, 157:104-113.
25. Pogwizd S.M., Bers D.M. Cellular basis of triggered arrhythmias in heart failure. Trends Cardiovasc. Med. 2004, 14:61-66.
26. Ren X.P., Wu J., Wang X., Sartor M.A., Qian J., Jones K., Nicolaou P., Pritchard T.J., Fan G.C. MicroRNA-320 is involved in the regulation of cardiac ischemia/reperfusion injury by targeting heat-shock protein 20. Circulation 2009, 119:2357-2366.
27. Roeters van Lennep J.E., Westerveld H.T., Erkelens D.W., van der Wall E.E. Risk factors for coronary heart disease: implications of gender. Cardiovasc. Res. 2002, 53:538-549.
28. Roger V.L., Go A.S., Lloyd-Jones D.M., Benjamin E.J., Berry J.D., Borden W.B., Bravata D.M., Dai S., Ford E.S., Fox C.S., Fullerton H.J., Gillespie C., Hailpern S.M., Heit J.A., Howard V.J., Kissela B.M., Kittner S.J., Lackland D.T., Lichtman J.H., Lisabeth L.D., Makuc D.M., Marcus G.M., Marelli A., Matchar D.B., Moy C.S., Mozaffarian D., Mussolino M.E., Nichol G., Paynter N.P., Soliman E.Z., Sorlie P.D., Sotoodehnia N., Turan T.N., Virani S.S., Wong N.D., Woo D., Turner M.B. Heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation 2012, 125:e2-e220.
29. Scherlag B.J., el-Sherif N., Hope R., Lazzara R. Characterization and localization of ventricular arrhythmias resulting from myocardial ischemia and infarction. Circ. Res. 1974, 35:372-383.
30. Shankar A., Teppala S., Sabanayagam C. Bisphenol A and peripheral arterial disease: results from the NHANES. Environ. Health Perspect. 2012, 120:1297-1300.
31. Skrzypiec-Spring M., Grotthus B., Szelag A., Schulz R. Isolated heart perfusion according to Langendorff - still viable in the new millennium. J. Pharmacol. Toxicol. Methods 2007, 55:113-126.
32. Vaccarino V., Parsons L., Every N.R., Barron H.V., Krumholz H.M. Sex-based differences in early mortality after myocardial infarction. National Registry of Myocardial Infarction 2 Participants. N. Engl. J. Med. 1999, 341:217-225.
33. Vandenberg L.N., Hauser R., Marcus M., Olea N., Welshons W.V. Human exposure to bisphenol A (BPA). Reprod. Toxicol. 2007, 24:139-177.
34. Vandenberg L.N., Chahoud I., Heindel J.J., Padmanabhan V., Paumgartten F.J., Schoenfelder G. Urinary, circulating, and tissue biomonitoring studies indicate widespread exposure to bisphenol A. Environ. Health Perspect. 2010, 118:1055-1070.
35. Wolff T., Miller T., Ko S. Aspirin for the primary prevention of cardiovascular events: an update of the evidence for the U.S. Preventive Services Task Force. Ann. Int. Med. 2009, 150:405-410.
36. Yamazaki S., Fujibayashi Y., Rajagopalan R.E., Meerbaum S., Corday E. Effects of staged versus sudden reperfusion after acute coronary occlusion in the dog. J. Am. Coll. Cardiol. 1986, 7:564-572.
37. Yan S., Chen Y., Dong M., Song W., Belcher S.M., Wang H.-S. Bisphenol A and 17β-estradiol promote arrhythmia in the female heart via alteration of calcium handling. PLoS One 2011, 6:e25455.
38. Yap Y.G., Duong T., Bland M., Malik M., Torp-Pedersen C., Kober L., Connolly S.J., Marchant B., Camm J. Temporal trends on the risk of arrhythmic vs. non-arrhythmic deaths in high-risk patients after myocardial infarction: a combined analysis from multicentre trials. Eur. Heart J. 2005, 26:1385-1393.
39. Zhang Z., Fang J., Gillespie C., Wang G., Hong Y., Yoon P.W. Age-specific gender differences in in-hospital mortality by type of acute myocardial infarction. Am. J. Cardiol. 2012, 109:1097-1103.